Halozyme Therapeutics reported $61.63M in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
DBV Technologies DBVT:US USD -17287000 5.75M
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Amarin AMRN:US USD -5140000 64.82M
Amgen AMGN:US USD 2.14B 826M
Aptinyx Inc APTX:US USD -15303000 2.36M
Baxter International BAX:US USD -2937000000 3.19B
Cara Therapeutics CARA:US USD -23180000 18.97M
Cytokinetics CYTK:US USD -142310000 122.49M
Eli Lilly And LLY:US USD 1.45B 499.2M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Immunogen IMGN:US USD -77755000 15.73M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Intra Cellular Therapies ITCI:US USD -53508000 33.1M
Intrexon XON:US USD 87.38M 105.01M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Mannkind MNKD:US USD -14432000 14.59M
Minerva Neurosciences NERV:US USD -6901000 1.82M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Peregrine Pharmaceuticals PPHM:US USD 1.56M 114.03M
Pfizer PFE:US USD 8.61B 1.3B
Rigel Pharmaceuticals RIGL:US USD -19037000 5.54M
United Therapeutics UTHR:US USD 239.3M 123.3M